BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38106559)

  • 21. The contribution of SARS-CoV-2 to the burden of acute respiratory infections in winter season 2022/2023: results from the DigiHero study.
    Glaser N; Diexer S; Klee B; Purschke O; Binder M; Frese T; Girndt M; Höll J; Moor I; Rosendahl J; Gekle M; Sedding D; Mikolajczyk R; Gottschick C
    Int J Infect Dis; 2024 Jul; 144():107057. PubMed ID: 38631507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021.
    ; Wulf Hanson S; Abbafati C; Aerts JG; Al-Aly Z; Ashbaugh C; Ballouz T; Blyuss O; Bobkova P; Bonsel G; Borzakova S; Buonsenso D; Butnaru D; Carter A; Chu H; De Rose C; Diab MM; Ekbom E; El Tantawi M; Fomin V; Frithiof R; Gamirova A; Glybochko PV; Haagsma JA; Haghjooy Javanmard S; Hamilton EB; Harris G; Heijenbrok-Kal MH; Helbok R; Hellemons ME; Hillus D; Huijts SM; Hultström M; Jassat W; Kurth F; Larsson IM; Lipcsey M; Liu C; Loflin CD; Malinovschi A; Mao W; Mazankova L; McCulloch D; Menges D; Mohammadifard N; Munblit D; Nekliudov NA; Ogbuoji O; Osmanov IM; Peñalvo JL; Petersen MS; Puhan MA; Rahman M; Rass V; Reinig N; Ribbers GM; Ricchiuto A; Rubertsson S; Samitova E; Sarrafzadegan N; Shikhaleva A; Simpson KE; Sinatti D; Soriano JB; Spiridonova E; Steinbeis F; Svistunov AA; Valentini P; van de Water BJ; van den Berg-Emons R; Wallin E; Witzenrath M; Wu Y; Xu H; Zoller T; Adolph C; Albright J; Amlag JO; Aravkin AY; Bang-Jensen BL; Bisignano C; Castellano R; Castro E; Chakrabarti S; Collins JK; Dai X; Daoud F; Dapper C; Deen A; Duncan BB; Erickson M; Ewald SB; Ferrari AJ; Flaxman AD; Fullman N; Gamkrelidze A; Giles JR; Guo G; Hay SI; He J; Helak M; Hulland EN; Kereselidze M; Krohn KJ; Lazzar-Atwood A; Lindstrom A; Lozano R; Malta DC; Månsson J; Mantilla Herrera AM; Mokdad AH; Monasta L; Nomura S; Pasovic M; Pigott DM; Reiner RC; Reinke G; Ribeiro ALP; Santomauro DF; Sholokhov A; Spurlock EE; Walcott R; Walker A; Wiysonge CS; Zheng P; Bettger JP; Murray CJL; Vos T
    JAMA; 2022 Oct; 328(16):1604-1615. PubMed ID: 36215063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long COVID symptoms in SARS-CoV-2-positive children aged 0-14 years and matched controls in Denmark (LongCOVIDKidsDK): a national, cross-sectional study.
    Kikkenborg Berg S; Palm P; Nygaard U; Bundgaard H; Petersen MNS; Rosenkilde S; Thorsted AB; Ersbøll AK; Thygesen LC; Nielsen SD; Vinggaard Christensen A
    Lancet Child Adolesc Health; 2022 Sep; 6(9):614-623. PubMed ID: 35752194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three-Month Symptom Profiles Among Symptomatic Adults With Positive and Negative Severe Acute Respiratory Syndrome Coronavirus 2 Tests: A Prospective Cohort Study From the INSPIRE Group.
    Spatz ES; Gottlieb M; Wisk LE; Anderson J; Chang AM; Gentile NL; Hill MJ; Huebinger RM; Idris AH; Kinsman J; Koo K; Li SX; McDonald S; Plumb ID; Rodriguez RM; Saydah S; Slovis B; Stephens KA; Unger ER; Wang RC; Yu H; Hota B; Elmore JG; Weinstein RA; Venkatesh A
    Clin Infect Dis; 2023 May; 76(9):1559-1566. PubMed ID: 36573005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term health consequences among individuals with SARS-CoV-2 infection compared to individuals without infection: results of the population-based cohort study CoMoLo Follow-up.
    Heidemann C; Sarganas G; Du Y; Gaertner B; Poethko-Müller C; Cohrdes C; Schmidt S; Schlaud M; Scheidt-Nave C
    BMC Public Health; 2023 Aug; 23(1):1587. PubMed ID: 37605232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
    Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ
    Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): a national, cross-sectional study.
    Kikkenborg Berg S; Dam Nielsen S; Nygaard U; Bundgaard H; Palm P; Rotvig C; Vinggaard Christensen A
    Lancet Child Adolesc Health; 2022 Apr; 6(4):240-248. PubMed ID: 35143771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary Function and Long-Term Respiratory Symptoms in Children and Adolescents After COVID-19.
    Knoke L; Schlegtendal A; Maier C; Eitner L; Lücke T; Brinkmann F
    Front Pediatr; 2022; 10():851008. PubMed ID: 35547532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and Severity of Symptoms 3 Months After Infection With SARS-CoV-2 Compared to Test-Negative and Population Controls in the Netherlands.
    van der Maaden T; Mutubuki EN; de Bruijn S; Leung KY; Knoop H; Slootweg J; Tulen AD; Wong A; van Hoek AJ; Franz E; van den Wijngaard CC
    J Infect Dis; 2023 Apr; 227(9):1059-1067. PubMed ID: 36477364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-acute symptoms 3-15 months after COVID-19 among unvaccinated and vaccinated individuals with a breakthrough infection.
    Brunvoll SH; Nygaard AB; Fagerland MW; Holland P; Ellingjord-Dale M; Dahl JA; Søraas A
    Int J Infect Dis; 2023 Jan; 126():10-13. PubMed ID: 36375693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection.
    Richard SA; Pollett SD; Fries AC; Berjohn CM; Maves RC; Lalani T; Smith AG; Mody RM; Ganesan A; Colombo RE; Lindholm DA; Morris MJ; Huprikar N; Colombo CJ; Madar C; Jones M; Larson DT; Bazan SE; Mende K; Saunders D; Livezey J; Lanteri CA; Scher AI; Byrne C; Rusiecki J; Ewers E; Epsi NJ; Rozman JS; English C; Simons MP; Tribble DR; Agan BK; Burgess TH;
    JAMA Netw Open; 2023 Jan; 6(1):e2251360. PubMed ID: 36652247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.
    Reis S; Metzendorf MI; Kuehn R; Popp M; Gagyor I; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD015395. PubMed ID: 38032024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection.
    Captur G; Moon JC; Topriceanu CC; Joy G; Swadling L; Hallqvist J; Doykov I; Patel N; Spiewak J; Baldwin T; Hamblin M; Menacho K; Fontana M; Treibel TA; Manisty C; O'Brien B; Gibbons JM; Pade C; Brooks T; Altmann DM; Boyton RJ; McKnight Á; Maini MK; Noursadeghi M; Mills K; Heywood WE;
    EBioMedicine; 2022 Nov; 85():104293. PubMed ID: 36182629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: a longitudinal population-based study (COVIDENCE UK).
    Tydeman F; Pfeffer PE; Vivaldi G; Holt H; Talaei M; Jolliffe D; Davies G; Lyons RA; Griffiths C; Kee F; Sheikh A; Shaheen SO; Martineau AR
    Thorax; 2023 Aug; 78(8):752-759. PubMed ID: 36423925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistent symptoms following SARS-CoV-2 infection amongst children and young people: A meta-analysis of controlled and uncontrolled studies.
    Behnood SA; Shafran R; Bennett SD; Zhang AXD; O'Mahoney LL; Stephenson TJ; Ladhani SN; De Stavola BL; Viner RM; Swann OV
    J Infect; 2022 Feb; 84(2):158-170. PubMed ID: 34813820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-Term Consequences of Asymptomatic SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis.
    Ma Y; Deng J; Liu Q; Du M; Liu M; Liu J
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Nonhospitalized Patients.
    Fernández-de-Las-Peñas C; Rodríguez-Jiménez J; Cancela-Cilleruelo I; Guerrero-Peral A; Martín-Guerrero JD; García-Azorín D; Cornejo-Mazzuchelli A; Hernández-Barrera V; Pellicer-Valero OJ
    JAMA Netw Open; 2022 Nov; 5(11):e2242106. PubMed ID: 36378309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal Household Assessment of Respiratory Illness in Children and Parents During the COVID-19 Pandemic.
    de Hoog MLA; Sluiter-Post JGC; Westerhof I; Fourie E; Heuvelman VD; Boom TT; Euser SM; Badoux P; Reusken C; Bont LJ; Sanders EAM; Jaddoe VWV; Herpers BL; Eggink D; Wildenbeest JG; Duijts L; van Houten MA; Bruijning-Verhagen PCJL
    JAMA Netw Open; 2022 Oct; 5(10):e2237522. PubMed ID: 36264578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symptom Clusters in Acute SARS-CoV-2 Infection and Long COVID Fatigue in Male and Female Outpatients.
    Leone V; Freuer D; Goßlau Y; Kirchberger I; Warm T; Hyhlik-Dürr A; Meisinger C; Linseisen J
    J Pers Med; 2024 Jun; 14(6):. PubMed ID: 38929823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.